Kriti Mehrotra
While Cindy Eckert is no stranger to the limelight, considering her entrepreneurial work in pharmaceuticals, she has received a lot of attention for her advocacy in the past few years alone. After all, as explored in Paramount+’s ‘The Pink Pill: Sex, Drugs & Who Has Control,’ she has been advocating for and working towards advancements in women’s sexual health since the early 2010s. Throughout the process, she has admittedly faced several ups and downs, but she vehemently continues on the path she has carved for herself with the sole aim of helping others.
How Did Cindy Eckert Earn Her Money?
Although a native of New York, Cindy Eckert spent the majority of her childhood abroad alongside her father since he was a US Ambassador to Fiji, which ingrained in her quite a global perspective. She maintained this standing as she returned to the US at age 18 to pursue a Bachelor’s degree in Business Administration in Marymount University in Arlington County, Virgina. She graduated in 1994, six months after which she was hired at one of the world’s largest drug companies, Merck, after having realized she wanted to work in a reputable brand.
Cindy admittedly had no passion for pharmaceuticals at the time, but she had realized while earning her degree that brand names/reputations matter a lot, so she deemed it the best possible outcome. She served there for a few years before heeding the advice of her brother and leaving the corporate world to find her calling with s smaller team to as to really focus on efficiiency. She subsequently joined the specialty pharmaceutical company Dura and Elan, only to soon shift gears by working in an advertising agency called McCann Erickson and then heading to QVC for better brand connections.
In the end, in 2005, Cindy and her then-husband Bob Whitehead decided to move to Raleigh, North Carolina, for good, which is where they established their own pharmaceutical company. Slate Pharmaceuticals was their first endeavor in 2007, through which they came out with a long-acting, Food and Drug Administration (FDA) approved testosterone pellet by the name of Testopel. Everything seemed to be going great, but things changed in 2010 after the FDA came after them for alleged misleading marketing, ultimately culminating in them selling the business to Actient in 2011.
By this point, the couple had also established Sprout Pharmaceuticals, which they used to focus on women’s sexual health, desire, needs, and more through a then-experimental drug. Addyi (inspired by Kate Walsh’s character on ‘Grey’s Anatomy) was in the early phases at the time, but Cindy worked hard to ensure it was safe and spent the ensuing 4 years towards the “Pink Pill.” After 2 failed attempts, the so-called female Viagra to boost a woman’s sex drive was finally approved by the FDA in 2015 – it got a 16-8 positive vote – resulting in its quick launch.
It was not long after the FDA approval that Sprout was acquired by Valeant Pharmaceuticals, with them promising to keep the original team for Addyi on board and investing in its sales. However, as per the aforementioned show, what came to be was a drug pricing scandal, and her team was invited to step away, so she lost the title of CEO. In the time to follow, she established a “Pinkubator” and a venture investment/consulting firm called The Pink Ceiling in 2016, only to later sue Valeant for breach of contract. In November 2017, she re-acquired Sprout Pharmaceuticals as a part of a settlement to drop her case, which resulted in her gaining back all her hard work and the title of CEO.
Cindy Eckert’s Net Worth
Since Cindy has been a significant player in the corporate world, the pharmaceutical industry, and female entrepreneurship over the past couple of decades, it goes without saying that she has accumulated significant wealth. Unfortunately, it is almost impossible to calculate her precise income and profits over the years since she has understandably preferred to keep her financial details well out of the limelight, but we do have some estimates. Based on her qualifications, the industry standards, and her hard work when she first kick-started her career, she likely got to walk away with a salary of at least $50,000 per year in the mid to late 1990s.
Then, with Cindy able in low-level pharmaceuticals, advertising, and QVC, she bagged around $50,00 to $60,000 in the early 2000s before launching her own business. With the success of Slate Pharmaceuticals in the field of male sexual health and Sprout Pharmaceuticals in the area of female sexual health, it appears as if she and her co-owner husband likely made millions by the time the late 2000s rolled around. Then, the couple sold Slate to Actient Pharmaceuticals for a whopping $500 million in 2011 and Srpout to Valeant Pharmaceuticals for an even more astounding $1 billion in 2015.
By this point, having parted ways with Bob Whitehead, Cindy was reportedly running the show mostly on her own, so she suffered with all the controversies surrounding the “Pink Pill.” Nevertheless, she persevered and launched her Pink Ceiling investment firm/incubator with the goal of supporting female-led organizations in any capacity, which helped her get back on her feet. As of writing, Pink Ceiling has invested in over 11 start-ups, including Undercover Color, Lia Diagnostics, and Pursuit, and when Sprout Pharmaceuticals came back to Cindy, she acquired it under the umbrella of her investment firm. Thus, taking all these aspects into consideration, Cindy’s current standing as CEO, her social media presence, her advocacy work, her potential assets, investments, and returns, and her lifestyle in Raleigh, North Carolina, we believe she has a net worth of $2 billion.
Read More: What is Julia Haart’s Net Worth?
